Breathing is something most of us take for granted, but for individuals with spinal cord injuries or chronic respiratory conditions, every breath can be a challenge. The Synapse Diaphragm Pacing System (DPS) is a new medical innovation that is transforming the lives of patients who struggle with respiratory issues.
We at Aurora Bioscience are committed to bringing life-changing medical solutions to Australia and New Zealand to help those in need. Through our partnership with Synapse, we are proud to bring attention to Synapse DPS, a device that enhances respiratory function, improves patient independence, and provides a better quality of life.
In this blog we’ll explore what the Synapse DPS is, how it works, and real-life stories of patients who have benefited from this innovation.
What is the Synapse Diaphragm Pacing System?
Diaphragm Pacing Technology is a revolutionary medical device designed to stimulate the diaphragm in individuals who experience breathing and respiratory issues. Unlike traditional ventilators, which force air into the lungs, DPS works by sending electrical signals to the diaphragm, encouraging natural breathing patterns.
This technology is particularly beneficial for:
- Patients with high spinal cord injuries
- Individuals with chronic respiratory failure
- Those affected by neuromuscular disorders
How Does It Work?
The Synapse DPS consists of a small, implantable device that delivers mild electrical pulses to the diaphragm. These pulses help the muscle contract and expand, allowing patients to breathe more naturally. Over time, this system can reduce the reliance on mechanical ventilation and improve respiratory function.
Key benefits of the Synapse DPS include:
- Greater independence from mechanical ventilators
- Improved speech capabilities
- Enhanced mobility
- Increased quality of life and autonomy
Check out these individuals who have benefited from DPS:
One of the most heart warming success stories comes from 12 year old Kobe, a young Australian who was the first child to receive the Synapse DPS. Before his procedure, Kobe’s respiratory challenges limited his ability to enjoy everyday activities that most kids participate in. Thanks to DPS, he now has greater breathing independence and a more active and fun lifestyle. Read more here.
Further, Christopher Reeve, an advocate for spinal cord injury research, was among the first public figures to support diaphragm pacing technology. CNN released an article highlighting this amazing story alongside the release of his new documentary, ‘Super/Man: Christopher Reeve Story’’ (2024). Reeve’s advocacy has help pave the way for medical advancements that now offers real hope to patients worldwide. Read more here.
Where Can You Access the Synapse DPS?
Aurora Bioscience is committed to ensuring that our Australian and New Zealand clients have access to the latest medical innovations and advancements. As a partner of Synapse, we offer support for clinicians, hospitals, and families exploring DPS as a treatment option.
The Synapse Diaphragm Pacing System is more than just a medical device, it’s a life changing solution for individuals with respiratory challenges. Whether it’s young patients like Kobe regaining independence or the ongoing legacy of Christopher Reeve’s advocacy, this technology is shaping the future of respiratory care.
At Aurora Bioscience, we are proud to play a role in delivering this innovation to those who need it most.
If you believe a patient could benefit from the Synapse Diaphragm Pacing System, we encourage you to reach out.
Contact us today to learn more.
Image Source: Warner Bros. Pictures/CNN